Cutaneous Melanoma: A 2023 Update and Management Pearls (2023 AMW) Session
2023 AAO-HNSF Annual Meeting & OTO Experience
PROGRAM DESCRIPTION: The management of cutaneous head and neck melanoma experienced transformational change over the past several years. This Expert Series provides a contemporary, case-based, concise framework to highlight these changes. The work-up and treatment options for our melanoma patients will be reviewed in an evidence-based fashion. Sentinel node biopsy techniques and pearls will be shared along with the utility of a completion neck dissection in the context of the MSLT-II trial. New advances in targeted therapy to include PD-1 inhibitors and associated clinical trials will be reviewed so that physicians can hold meaningful patient conversations regarding adjuvant treatment options. We will highlight the important changes and associated challenges we face in managing our complex melanoma patients. Participants will leave this 1-hour course with a clear understanding of 2023 standard of care for cutaneous head and neck melanoma.OUTCOME OBJECTIVE 1: List 2023 evidence-based melanoma guidelines for work-up & staging to include radiographic imaging and sentinel node biopsyOUTCOME OBJECTIVE 2: Define the utility of a completion neck dissection in the setting of a positive sentinel node given recent MSLT-II trial resultsOUTCOME OBJECTIVE 3: Formulate a plan to educate patients on melanoma adjuvant therapy to include novel targeted treatment optionsBACKGROUND STATEMENT: A concise melanoma review is of benefit to our AAO-HNS members given the recent introduction of novel targeted therapies (PD-1 inhibitors) & the long awaited MSLT-II results which now question the role of completion neck dissection following a positive sentinel node biopsy.